✦ LIBER ✦

Retreatment of patients with chronic hepatitis C

✍ Scribed by Mitchell L. Shiffman

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 735 KB
Volume: 36
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840360717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of retreatment with interfero

The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C

✍ Hidenori Toyoda; Takashi Kumada; Satoshi Nakano; Isao Takeda; Keiichi Sugiyama; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those

Better efficacy of a 12-month interferon

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of

Chronic hepatitis C: Interferon retreatm

Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data

✍ Calogero Cammà; Marco Giunta; Liliana Chemello; Alfredo Alberti; Hidenori Toyoda 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

the other members of the European Concerted Action on Viral Hepatitis Group are listed in the Appendix.

Retreatment of chronic hepatitis B e ant

Retreatment of chronic hepatitis B e antigen–positive patients with recombinant interferon alfa-2a

✍ Vicente Carreño; Patrick Marcellin; Stephanos Hadziyannis; Javier Salmerón; Mois 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Hepatitis B vaccination in patients with

Hepatitis B vaccination in patients with chronic hepatitis C

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Lu, Rei-Hwa; Chang, Full-Young; Lo, K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Noninvasive monitoring of patients with

Noninvasive monitoring of patients with chronic hepatitis C

✍ Robert J. Fontana; Anna S. F. Lok 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Hepatic fibrosis is the main determinant of clinical outcomes of chronic hepatitis C. Liver histology is frequently considered the gold standard for assessing hepatic fibrosis. However, liver biopsy is associated with sampling error, interobserver variability, and potential complications. Thus, ther